8-KEarnings & ResultsExhibits & Filings

ELI LILLY & Co 8-K Report, Financial Results (Jul 23, 2015)

Filed July 23, 2015For Securities:LLY

Summary

Eli Lilly and Company (LLY) filed an 8-K on July 23, 2015, to report its financial results for the second quarter and the first six months of 2015. The filing includes a press release detailing these results and references a teleconference held for analysts and media. Key to this report is Lilly's use of non-GAAP financial measures, such as non-GAAP net income and earnings per share. The company explains that these adjustments exclude items like amortization of acquired intangible assets and other variable, unpredictable costs. Lilly believes these non-GAAP figures offer investors a clearer view of ongoing operations, facilitate period-over-period comparisons, and help identify underlying operating trends that GAAP measures might obscure. Management also utilizes these non-GAAP metrics for internal performance evaluation and resource allocation.

Key Highlights

  • 1Eli Lilly announced its second quarter and six-month financial results for 2015 via an 8-K filing on July 23, 2015.
  • 2The company held a teleconference for analysts and media to discuss the reported financial outcomes.
  • 3Lilly utilizes and presents non-GAAP financial measures, including non-GAAP net income and earnings per share, in its reporting.
  • 4These non-GAAP measures are adjusted to exclude items such as amortization of acquired intangible assets.
  • 5Other highly variable and unpredictable items are also excluded from non-GAAP calculations.
  • 6Lilly asserts that these non-GAAP measures provide investors with a better understanding of ongoing operations and facilitate trend analysis.
  • 7The information provided in the 8-K, including the press release, is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report Eli Lilly and Company's financial results for the second quarter and the six-month period ended June 30, 2015, as announced in their press release on July 23, 2015.

Eli Lilly uses non-GAAP financial measures, such as non-GAAP net income and earnings per share, to provide investors with a clearer view of the company's ongoing operations. These measures adjust for the impact of significant acquisitions/divestitures, amortization of acquired intangibles, and other unpredictable items, aiming to facilitate meaningful comparisons and identify underlying operating trends.

Investors should consider Lilly's non-GAAP measures in addition to, not as a substitute for or superior to, GAAP measures. The company provides these non-GAAP figures because they believe they offer useful insights into ongoing operations, but they are not intended to replace the standard financial statements prepared according to GAAP.

The detailed financial results, including the press release and related financial statements, are attached to this Form 8-K as Exhibit 99.1. This exhibit contains the specific income statements and other financial information for the periods reported.